Skip to content. | Skip to navigation

European Coalition on Homeopathic & Anthroposophic Medicinal Products

Navigation

Antimicrobial resistance

EU action in public health gives priority to tackling the emerging global threat of antimicrobial resistance and over-prescription of antibiotics in primary care, a growing global problem with important consequences such as increased mortality and economic impact. It is estimated that resistance to antibiotics results in 25,000 deaths per year in the EU and costs the EU EUR 1.5 billion per year in healthcare costs and productivity losses. The use of effective and safe non-antibiotic treatments of infections is one of the strategies to reduce (inappropriate) use of antibiotics.

In this context, homeopathy and anthroposophic medicine have an important role to play - the use of anthroposophic medicine has been associated with much lower use of  antibiotics  and  antipyretics, quicker  recovery,  fewer  adverse  reactions, and  greater  therapy  satisfaction compared to conventional medicine. Similar results have been seen in homeopathy, with one study, for example, showing lower use of antibiotics and fewer antipyretic/anti-inflammatory drugs for a similar clinical evolution.

Related content

Last updated on 22 May 2019